• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Uncertainty of 2022

Quote

anonymous

Guest
Everyone at Biogen ponders if they will have a job or not going into January 2022. It has been a very tough year. Here is hoping Biogen at least does one thing right by properly treating their loyal employees well and taking care of them in a generous fashion. It is the right thing to do.
 




anonymous said:
Everyone at Biogen ponders if they will have a job or not going into January 2022. It has been a very tough year. Here is hoping Biogen at least does one thing right by properly treating their loyal employees well and taking care of them in a generous fashion. It is the right thing to do.
Click to expand...

Is the right thing to do the *best* thing to do for Biogen strategically? Probably not. The company cares more about making scientific progress than its employee's personal and professional development.
 




Biogen is under the microscope now. Employees are being interviewed through various sources. If they treat the employees poorly, this will further tarnish their reputation to the outside world. All eyes are now ready to see what they will do.
 




















Not sure what the new formula will be, but I got 2 weeks for every year of service. There was also guardrails put in place with some stipulations that were very vague, but the key one was severance being capped at 17 weeks pay no matter your tenure.
 








anonymous said:
Not sure what the new formula will be, but I got 2 weeks for every year of service. There was also guardrails put in place with some stipulations that were very vague, but the key one was severance being capped at 17 weeks pay no matter your tenure.
Click to expand...


I hope you are wrong as that is pathetic. Thankfully with the WARN act, they have to hit minimums. If they end up giving terrible packages, it will serve them right it is leaked to the press.
 












<3 years at Biogen for Jeff Capello.

15 months of health benefits from Biogen.
16 months of salary and expected bonus payout.
And another 2.6M on top to stuff his mouth and not say anything disparaging.

Not for the peasants.
 




















anonymous said:
It'll be just like this one [Not!]. I mean he had 2.5 "years of service" which Biogen

Document

Former Biogen CFO Capello scores $2.6M payment plus full severance benefits on his way out
Click to expand...

This aged well.

“On Biogen’s July conference call, CEO Michel Vounatsos pointed out that together with Capello, the team “delivered on 18 deals,” though most were for early-stage programs. He said aducanumab is the company’s “one big hope” until those early-stage research projects advance toward the market in 2024 or 2025.”
 












Top Bottom
Back
Quote